Thiamine Side Effects

Reported Thiamine side effects

Thiamine is among the safest vitamins known. At RDA-range dietary intake and even at pharmacologic oral doses (hundreds of milligrams per day), thiamine has no characteristic dose-limiting toxicity. The body does not substantially store thiamine, excess is rapidly excreted in the urine, and no well-documented organ toxicity has been associated with chronic high-dose oral use at supplement range. This is distinctly different from vitamin B6 (sensory neuropathy at chronic multi-hundred-milligram doses; see the Vitamin B6 entry) or fat-soluble vitamins (hypervitaminosis A, D toxicity) — thiamine is one of the most forgiving water-soluble vitamins at supraphysiologic doses. The Institute of Medicine did not establish a formal tolerable upper intake level for thiamine citing the lack of adverse effect signal across human exposure data. The principal safety concern with thiamine is intravenous anaphylaxis. Rare but well-documented hypersensitivity reactions to IV thiamine have produced case reports of anaphylaxis and death since the 1940s. Stephen and Hanson's classic series documented the phenomenon, and it is the reason that hospital protocols administer IV thiamine over 30 minutes rather than as rapid push, and usually in the presence of resuscitation capability. The incidence of serious IV thiamine reactions is extremely low (~1 per million or rarer), and the clinical benefit of IV thiamine in suspected Wernicke's vastly outweighs this risk — but emergency medicine practice continues to include resuscitation-ready IV administration. Intramuscular thiamine rarely causes local injection site reactions and has a lower anaphylaxis risk than IV administration. Oral thiamine has no reported anaphylaxis risk. Other reported thiamine effects at high-dose use: nausea, restlessness, mild flushing or warmth sensation with IV administration, rare urticarial skin reactions, sweating, and transient tachycardia. Chronic oral high-dose thiamine at hundreds of milligrams per day has not been linked to any organ toxicity in published case series. Glucose-before-thiamine caution in alcoholics and the malnourished. This is a pharmacologic interaction of the first importance. In a thiamine-depleted patient, IV glucose administration rapidly drives pyruvate into the PDH step and α-ketoglutarate into the αKGDH step, both of which require TPP; the sudden demand can precipitate acute Wernicke encephalopathy within hours in a patient who was compensated before the glucose load. For this reason, any alcoholic or malnourished patient receiving IV glucose should receive thiamine concurrently or before — the standard ED teaching is "thiamine before glucose" in the unresponsive alcoholic patient, with both often given together in practice. Benfotiamine side effects mirror thiamine's with occasional mild GI upset, bodily warmth, and rare skin reactions. Benfotiamine's S-benzoate liberation has been theoretically linked to benzoate accumulation concerns in patients with urea cycle defects, though this is rarely clinically relevant at standard doses. Sulbutiamine side effects are discussed in the Sulbutiamine entry and include mild hyperactivity, insomnia, and, rarely, hypomanic reactions in bipolar-spectrum patients — effects not typically seen with plain thiamine. Drug interactions. Thiamine as a vitamin has few clinically important drug interactions. Loop diuretics (furosemide, bumetanide) increase urinary thiamine loss — this is a reason to repelete, not a contraindication. 5-Fluorouracil and other fluoropyrimidine chemotherapeutics can precipitate Wernicke-like syndromes in thiamine-depleted patients; prophylactic thiamine is sometimes recommended during chemotherapy. Chronic alcohol obviously depletes thiamine through multiple mechanisms. Phenobarbital, phenytoin, and carbamazepine can modestly lower thiamine levels. Oral contraceptives do not substantially affect thiamine. Pregnancy and lactation. RDA-range thiamine (1.4 mg/day) is safe and recommended. Hyperemesis gravidarum cases require prophylactic thiamine at 100 mg IM/IV to prevent maternal Wernicke's and fetal demise. Pyridoxine-doxylamine antiemetic (Diclegis) does not replace thiamine in HG. Breastfeeding safety at RDA range is established; high-dose maternal thiamine has not been associated with infant adverse effects. Pediatric use. RDA-range thiamine is essential in infancy. Infantile beriberi is a historical pediatric emergency largely abolished by grain fortification but reported in breastfed infants of thiamine-deficient mothers, in severely thiamine-poor infant formulas (the 2003 Israel formula scandal), and in medical feeding errors. Treatment is IV/IM thiamine 25-50 mg daily for several days with transition to oral maintenance. Biotin-thiamine-responsive basal ganglia disease is treated with high-dose thiamine and biotin from diagnosis. TRMA syndrome is managed lifelong with thiamine 25-100 mg/day. Laboratory monitoring. Plasma thiamine (via HPLC) and erythrocyte transketolase activity with TPP stimulation are the clinical tests of thiamine status. Urinary thiamine is useful for assessing intake over the preceding 24-48 hours. In acute Wernicke's, clinical diagnosis takes priority over laboratory confirmation — empiric treatment is initiated based on clinical suspicion. The cleanest safety summary: thiamine is extraordinarily safe at oral doses up to hundreds of milligrams per day; IV thiamine carries rare anaphylaxis risk mitigated by slow infusion and resuscitation-ready administration; the major interaction to know is "thiamine before glucose" in suspected deficiency; and most clinical use is limited by under-recognition of deficiency rather than by toxicity.

When to continue, reduce, or stop Thiamine

Thiamine contraindications

There are no absolute contraindications to oral thiamine supplementation at RDA-range or therapeutic doses; the compound is one of the safest vitamins known. Relative contraindications and cautions: Known hypersensitivity to thiamine or to excipients in a particular formulation is an absolute contraindication to re-administration of the offending product. IV thiamine with prior anaphylactoid reaction — switch to oral or IM route, or use very slow IV infusion with resuscitation capability if IV is essential. Glucose administration before thiamine in suspected deficiency — not a contraindication to thiamine, but the order matters: give thiamine first or concurrently with glucose in the altered alcoholic or malnourished patient. Pregnancy is not a contraindication; thiamine at RDA or therapeutic doses is safe and required in pregnancy. Hyperemesis gravidarum is an indication rather than contraindication; give 100 mg thiamine IV or IM with IV fluids to prevent Wernicke's and fetal demise. Breastfeeding is not a contraindication at RDA to therapeutic doses. Pediatric use is appropriate under pediatric supervision; infantile beriberi is treated with 25-50 mg IV/IM daily. Renal failure is not a contraindication but thiamine is removed by hemodialysis so maintenance doses should be timed after dialysis or increased on dialysis days. Hepatic failure is not a contraindication; alcoholic liver disease is a strong indication for thiamine supplementation. Known thiamine-responsive inborn errors of metabolism (TRMA, BTBGD) are indications for high-dose thiamine, not contraindications. There are no clinically important absolute drug-drug contraindications. The overall safety profile is such that the principal clinical risk of thiamine is failure to give it when indicated (under-recognition of Wernicke's) rather than any risk from giving it when not indicated.

Why vendor quality drives Thiamine side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

Thiamine side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .